Gordon Research Conference on Cancer Genetics and Epigenetics
07-09 April 2019 Dr. Gianluca Fossati, Head of Biochemistry and Molecular Biology at Italfarmaco will present at the forthcoming Gordon Research Conference on Cancer [...]
TRiNDS and Italfarmaco Announce US Patient Advocacy Partnership for EPIDYS Trial of Givinostat for Duchenne Muscular Dystrophy
Pittsburgh, PA, November 9, 2018 - Therapeutic Research in Neuromuscular Disorders Solutions (TRiNDS), a specialty contract research organization, and Italfarmaco SpA, a privately held [...]
World Duchenne Awareness Day 2018
Italfarmaco committed to its mission to contribute to the improvement of the quality and the prolongation of human lifespan, is proud to support the [...]
Acquisition of Effik, S.A.
Italfarmaco Group announces the acquisition of the remaining 50% of Effik, S.A.